Long-term impact on work and private life after Guillain–Barré syndrome

https://doi.org/10.1016/S0022-510X(02)00158-2Get rights and content

Abstract

Objective: To determine the long-term impact of Guillain–Barré syndrome (GBS) on work and private life of patients and their partners. Methods: Three to six years after the onset of GBS 150 patients who participated in the Dutch Guillain–Barré trial received a questionnaire specifically drafted for this study to survey their present psychosocial status. Furthermore, their present physical status was established. Results: A total of 122 patients participated. Thirty-one percent showed moderate to serious physical residua after a functional assessment. Due to GBS, 38% of the patients who held a job had to change it, 44% altered their leisure activities, 37% of the patients did not function as well at home as before GBS and 39% reported a change in their partners' lives. Almost half of the patients still had negative comments on their present psychosocial situation. Conclusion: GBS has a serious long-term impact on the patients' work and private life and that of their partners.

Introduction

Guillain–Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy. The main symptoms are muscle weakness, varying from mild paresis to complete paralysis of all voluntary muscles, and mild to moderate sensory changes. After a progressive phase of up to 4 weeks, the disease remains stable for about 2–4 weeks. Then a prolonged recovery phase begins, lasting 1–2 years. Ten to thirty-five percent of the patients have appreciable residual motor and/or sensory phenomena [1], [2], [3], [4]. These residua are usually distally localised in the upper and lower limbs. Many patients also continue to complain about fatigue and lack of condition. The long-term impact of these residual symptoms on ordinary life, for instance, on the situation at home, at work or on leisure activities can be extensive. This has been mentioned in some reports and personal experiences [1], [5], [6], [7], [8], [9], [10]. However, a systematic study on this subject had been lacking [11]. Therefore, we decided to study the psychosocial effects of GBS 2.5–6.5 years after the onset of the disease.

Section snippets

Patients

A total of 150 patients participated in the Dutch Guillain–Barré trial, comparing immunoglobulins intravenously with plasma exchange [12]. All patients met the criteria for acute GBS. They were included in the trial within 2 weeks of onset of the disease and were, at that time, unable to walk more than 10 m without a walker or support from another person. Of the 150 GBS patients who participated in the trial, 122 were available for our study 31–77 months after the acute phase of their disease.

General information

The group of patients consisted of 60 men and 62 women, ranging in age from 20 to 85 years. At the initial functional assessment, 26 patients scored F3, 75 scored F4 and 21 scored F5 (F5=ventilator dependent). At nadir, 6 patients had an F score of 3, 63 of 4 and 53 patients were ventilator dependent. In 36% of the patients, positive serology for Campylobacter jejuni was found.

Neurological residua

Eighty-four patients (69%) had no or unimportant residua (F is 0 or 1). Twenty-four (20%) showed a moderate recovery

Discussion

Thirty-one percent of our patients had moderate to severe residual signs. This level of final physical recovery is in accordance with other groups reported [1], [2], [3], [4] and once more accentuates the seriousness of residual signs in a considerable number of patients, even 2.5 or more years after GBS.

It is generally believed that no further recovery can be expected 2–3 years after GBS [16]. It is therefore remarkable that in our group, 21% of the patients still noticed improvement after

Acknowledgements

This project was supported by the foundation “De Drie Lichten” in the Netherlands.

References (21)

  • A.E.J. De Jager et al.

    Residual signs in severe Guillain–Barré syndrome: Analysis of 57 patients

    J. Neurol. Sci.

    (1991)
  • N.B. Löffel et al.

    The Landry–Guillain–Barré syndrome

    J. Neurol. Sci.

    (1977)
  • J.M. Meythaler

    Rehabilitation of Guillain–Barré syndrome

    Arch. Phys. Med. Rehabil.

    (1997)
  • H.P. Greenwald et al.

    Work disability among cancer patients

    Soc. Sci. Med.

    (1989)
  • The prognosis and main prognostic indicators of Guillain–Barré syndrome

    Brain

    (1996)
  • Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome

    Lancet

    (1997)
  • C.A. Vedeler et al.

    The long term prognosis of Guillain–Barré syndrome. Evaluation of prognostic factors including plasma exchange

    Acta Neurol. Scand.

    (1997)
  • D. Rice

    Landry–Guillain–Barré syndrome: Personal experience of acute ascending paralysis

    Br. Med. J.

    (1977)
  • S.M. Lennon et al.

    Reasons for persistent disability in Guillain–Barré syndrome

    Clin. Rehabil.

    (1993)
  • C.M. Chemtob et al.

    Post-traumatic stress disorder as a sequela of Guillain–Barré syndrome

    J. Trauma Stress

    (1994)
There are more references available in the full text version of this article.

Cited by (67)

  • Long-Term Neurological, Behavioral, Functional, Quality of Life, and School Performance Outcomes in Children With Guillain-Barré Syndrome Admitted to PICU

    2023, Pediatric Neurology
    Citation Excerpt :

    This therapeutic intervention probably resulted in better neurological recovery in our cohort. In a study from the Netherlands, Roodbol et al.7 followed up 37 children with GBS after 116-17 years of discharge and reported that 24 (65%) had residual complaints, which included paraesthesia in 14 (38%), unsteadiness of gait in the dark in 13 (37%), painful hands or feet in nine (24%), and severe fatigue in five (22% of the 23 children who completed the questionnaire) children. A wide range of behavioral issues and below-the-normal quality of life were also reported.

  • Guillain Barré syndrome - Incidence and clinical course in Southern Rogaland, Norway

    2016, Clinical Neurology and Neurosurgery
    Citation Excerpt :

    Comparing previous knowledge, we see that despite the improvement on the SF-36 throughout the period, the mean sum score for both physical function (PCS) and mental health (MHS) were lower than the values reported in a long-term follow-up study [9] and in line with the findings from a large Dutch survey [21] where self-reported outcome in inflammatory neuropathies remained markedly lower than among controls in a one year follow-up. Self-assessed disability and fatigue were higher in this study compared with long-term observations in GBS [8], but it has also been reported that patients with GBS report significant residual problems and make adaptive changes in their lives several year after the illness even though long term improvement is seen [31,32]. These findings underline that further improvement of self-assessed QoL, disability and fatigue may occur more than one year after onset, and that factors other than improvement of muscle strength and sensory dysfunction (e.g. coping mechanisms) could play a role.

  • The Guillain-Barré syndrome

    2013, Handbook of Clinical Neurology
  • Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome

    2012, Journal of the Neurological Sciences
    Citation Excerpt :

    Lately several studies stressed the central role of fatigue in the subjective limitation of daily activities, in spite of good recovery of muscle strength. For example, Bernsen et al [11] examined the functional handicap during daily life activities in 122 patients following GBS, 3–6 years after the acute disease, and reported that approximately 40% of the patients had to change their work or life style due to residual functional disability. In a similar study [12] among 70 patients examined 3–5 years after GBS, 27% reported changes in personal life style because of increased fatigability.

View all citing articles on Scopus
View full text